Results
Gujarat Themis Biosyn Q4 Revenue Up 17% YoY
Gujarat Themis Biosyn reported Q4 FY26 revenue of ₹44.23 crore, up 17.22% YoY, with EBITDA margin expanding 127 bps to 43.77%.
The company announced two major acquisitions: 13 brands from Sanofi for ~
